Company Filing History:
Years Active: 2024
Title: Youngger Suh: Innovator in Angiogenesis-Related Eye Disease Treatment
Introduction
Youngger Suh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of angiogenesis-associated eye diseases. His innovative work has led to the development of a novel therapeutic approach that holds promise for patients suffering from these conditions.
Latest Patents
Youngger Suh holds a patent for a hypoxia-inducible factor 1α (HIF-1α) inhibitor. The patent, titled "HIF-1α inhibitor, preparation method therefor, and pharmaceutical composition for preventing or treating angiogenesis-associated eye disease, containing same as active ingredient," describes a method for preparing this inhibitor. The compound is capable of effectively inhibiting HIF-1α, making it a valuable pharmaceutical composition for preventing or treating angiogenesis-related eye diseases.
Career Highlights
Youngger Suh is affiliated with Seoul National University, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential impact on treating serious eye conditions linked to abnormal blood vessel growth.
Collaborations
Youngger Suh collaborates with esteemed colleagues, including Seungbeom Lee and Jeonghun Kim. Their combined expertise enhances the research and development efforts in the field of ophthalmology.
Conclusion
Youngger Suh's contributions to the field of pharmaceuticals, particularly through his patent on HIF-1α inhibitors, represent a significant advancement in the treatment of angiogenesis-related eye diseases. His work continues to inspire further research and innovation in this critical area of healthcare.